Key Events This Week
Mar 09: Mojo Grade downgraded to Sell amid technical weakness
Mar 10: Bearish momentum confirmed with technical downgrade
Mar 13: Week closes at Rs.1,804.00 (+0.86%) outperforming Sensex
Apr 09
BSE+NSE Vol: 90.22 k

Metropolis Healthcare Ltd has seen a notable shift in its valuation parameters, moving from an expensive to a very expensive rating, driven by elevated price-to-earnings and price-to-book ratios. Despite recent positive price momentum, the company’s valuation now demands a closer examination against its historical averages and peer group, especially given its mixed return profile relative to the broader Sensex.
Read full news article
Metropolis Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Metropolis Healthcare Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness amid a challenging sector backdrop and peer comparisons.
Read full news article
Metropolis Healthcare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 09 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 March 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Metropolis Healthcare Ltd has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating, raising concerns about price attractiveness amid a challenging sector backdrop. Despite solid operational metrics, the stock’s elevated price-to-earnings and price-to-book ratios suggest investors should carefully weigh risk versus reward in the current market environment.
Read full news article
Mar 09: Mojo Grade downgraded to Sell amid technical weakness
Mar 10: Bearish momentum confirmed with technical downgrade
Mar 13: Week closes at Rs.1,804.00 (+0.86%) outperforming Sensex
Metropolis Healthcare Ltd has a recent bonus issue where they announced a 3:1 bonus. The ex-date for this bonus is set for March 20, 2026. This means that for every one share held, shareholders will receive three additional shares. If you have any further questions about the company or its financial actions, feel free to ask!...
Read full news article
Metropolis Healthcare Ltd has seen its investment rating downgraded from Hold to Sell as of 9 March 2026, driven primarily by deteriorating technical indicators and valuation pressures despite solid recent financial performance. The company’s Mojo Score has declined to 44.0, reflecting a cautious stance amid mixed fundamentals and bearish market signals.
Read full news article
Metropolis Healthcare Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. Following a downgrade from Hold to Sell on 9 March 2026, the stock’s price action and technical parameters suggest increasing downside risks amid broader market pressures.
Read full news articleCertificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2026
Business update for Q4FY26
Closure of Trading Window
No Upcoming Board Meetings
Metropolis Healthcare Ltd has declared 200% dividend, ex-date: 11 Nov 25
No Splits history available
Metropolis Healthcare Ltd has announced 3:1 bonus issue, ex-date: 20 Mar 26
No Rights history available